Abstract: Dental composite materials based on (meth)acrylate, exhibiting a proportion of TCD monomers in the total composition of 1-15% by weight and the quotient of flexural strength/shrinkage tension is at least 35.

Abstract: Dental composites comprising monomers, crosslinking agents, fillers, and initiators, in which the crosslinking agent comprises more than 50% by weight of the acrylate monomer TCD-DI-HEA, and the cyctotoxicity of the cured composite as determined according to the standard requirements of ISO 10993-5 and DIN EN ISO 7405 is assessed into the category “no cytotoxic potential”.

Abstract: For composite materials having a total filler content of 80 to 95% by weight, containing A) 0.5 to 10% by weight of non-agglomerated nanofillers having particle sizes of 1 to 50 nm in the filler component, B) at least 60% by weight of a filler mixture of 50 to 90% coarse-particle and 10 to 50% fine-particle dental glass in the filler component, having a size ratio, relative to the average particle size (d50 value), of coarse to fine particles of >1:4 to 1:30, C) as monomer component, a monomer mixture of i. 60 to 80% bis-GMA or TCD-di-HEMA or TCD-di-HEA, ii. 10 to 18% UDMA, iii. Residual TEDMA and/or multifunctional crosslinkers, D) up to 1% photoinitiator(s); and E) optionally, at least one additional dental glass in the filler component having a different particle size than the coarse- and fine-particle dental glass, the polymerization shrinkage may be reduced to <1.

Abstract: Dental composite materials based on (meth)acrylate, exhibiting a proportion of TCD monomers in the total composition of 1-15% by weight and the quotient of flexural strength/shrinkage tension is at least 35.

Abstract: Compositions for dental composites comprising monomers, crosslinking agents, fillers, initiators, A the proportion of crosslinking agent being formed in an amount of more than 50% by acrylate monomers with a TCD urethane structure having the general formula in which A, X, Z, R1 R2 R3 and r have the meaning indicated in claim 1, provide polymerized composite materials with a particularly low cytotoxicity according to the standard requirements according to ISO 10993-5 and DIN EN ISO 7405.

Abstract: For composite materials having a total filler content of 80 to 95% by weight, containing A) 0.5 to 10% by weight of non-agglomerated nanofillers having particle sizes of 1 to 50 nm in the filler component, B) at least 60% by weight of a filler mixture of 50 to 90% coarse-particle and 10 to 50% fine-particle dental glass in the filler component, having a size ratio, relative to the average particle size (d50 value), of coarse to fine particles of >1:4 to 1:30, C) as monomer component, a monomer mixture of i. 60 to 80% bis-GMA or TCD-di-HEMA or TCD-di-HEA, ii. 10 to 18% UDMA, iii. Residual TEDMA and/or multifunctional crosslinkers, D) up to 1% photoinitiator(s); and E) optionally, at least one additional dental glass in the filler component having a different particle size than the coarse- and fine-particle dental glass, the polymerization shrinkage may be reduced to <1.